Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) will release its third quarter 2025 financial results on Wednesday, October 29, 2025 after market close.

The company will host a conference call at 4:30 PM ET on October 29, 2025 to discuss the results and corporate activities; domestic dial-in is 1-888-596-4144, international 1-646-968-2525, passcode 8728050. A simultaneous webcast will be available and archived on www.vandapharma.com; investors should access the site at least 15 minutes early to register and install audio software.

A replay will be available beginning October 29, 2025 at 8:30 PM ET through November 5, 2025 at 11:59 PM ET; replay domestic number 1-800-770-2030, international 1-609-800-9909, passcode 8728050.

Conference Call and Webcast to Follow

WASHINGTON, Oct. 22, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2025 on Wednesday, October 29, 2025, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, October 29, 2025, during which management will discuss the third quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-888-596-4144 (domestic) or 1-646-968-2525 (international) and use passcode 8728050.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, October 29, 2025, beginning at 8:30 PM ET and will be accessible until Wednesday, November 5, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8728050.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2025-financial-results-on-october-29-2025-302591878.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda (VNDA) release third quarter 2025 results?

Vanda will release Q3 2025 results after market close on October 29, 2025.

What time is the Vanda (VNDA) conference call for Q3 2025 and how do I join?

The call is at 4:30 PM ET on October 29, 2025; dial 1-888-596-4144 (US) or 1-646-968-2525 (international) and use passcode 8728050.

Where can investors watch the Vanda (VNDA) webcast for the October 29, 2025 call?

The webcast will be broadcast and archived on www.vandapharma.com; register at least 15 minutes early.

When and how can I access the replay of Vanda (VNDA) Q3 2025 call?

Replay starts October 29, 2025 at 8:30 PM ET and is available until November 5, 2025 at 11:59 PM ET; replay numbers are 1-800-770-2030 (US) and 1-609-800-9909, passcode 8728050.

Do I need to install software to join Vanda's (VNDA) webcast?

Investors are advised to visit the website at least 15 minutes early to register and download any required audio software.

What topics will Vanda (VNDA) management discuss on the October 29, 2025 call?

Management will discuss third quarter 2025 financial results and other corporate activities.